Zurich Cantonal Bank’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-3,289
| Closed | -$32.4K | – | 2832 |
|
2023
Q1 | $32.4K | Hold |
3,289
| – | – | ﹤0.01% | 2688 |
|
2022
Q4 | $61.6K | Buy |
3,289
+1,006
| +44% | +$18.8K | ﹤0.01% | 2532 |
|
2022
Q3 | $47K | Hold |
2,283
| – | – | ﹤0.01% | 2614 |
|
2022
Q2 | $47K | Hold |
2,283
| – | – | ﹤0.01% | 2610 |
|
2022
Q1 | $98K | Hold |
2,283
| – | – | ﹤0.01% | 2294 |
|
2021
Q4 | $137K | Buy |
2,283
+658
| +40% | +$39.5K | ﹤0.01% | 2333 |
|
2021
Q3 | $140K | Hold |
1,625
| – | – | ﹤0.01% | 2140 |
|
2021
Q2 | $181K | Sell |
1,625
-293
| -15% | -$32.6K | ﹤0.01% | 1867 |
|
2021
Q1 | $214K | Hold |
1,918
| – | – | ﹤0.01% | 1740 |
|
2020
Q4 | $204K | Buy |
1,918
+592
| +45% | +$63K | ﹤0.01% | 1828 |
|
2020
Q3 | $185K | Hold |
1,326
| – | – | ﹤0.01% | 1644 |
|
2020
Q2 | $429K | Buy |
+1,326
| New | +$429K | ﹤0.01% | 1087 |
|
2019
Q4 | – | Sell |
-477
| Closed | -$12K | – | 2605 |
|
2019
Q3 | $12K | Hold |
477
| – | – | ﹤0.01% | 2529 |
|
2019
Q2 | $17K | Hold |
477
| – | – | ﹤0.01% | 2502 |
|
2019
Q1 | $21K | Hold |
477
| – | – | ﹤0.01% | 2400 |
|
2018
Q4 | $23K | Buy |
477
+280
| +142% | +$13.5K | ﹤0.01% | 2407 |
|
2018
Q3 | $13K | Hold |
197
| – | – | ﹤0.01% | 2528 |
|
2018
Q2 | $9K | Hold |
197
| – | – | ﹤0.01% | 2499 |
|
2018
Q1 | $11K | Hold |
197
| – | – | ﹤0.01% | 2479 |
|
2017
Q4 | $10K | Hold |
197
| – | – | ﹤0.01% | 2498 |
|
2017
Q3 | $15K | Hold |
197
| – | – | ﹤0.01% | 2344 |
|
2017
Q2 | $18K | Hold |
197
| – | – | ﹤0.01% | 2287 |
|
2017
Q1 | $16K | Hold |
197
| – | – | ﹤0.01% | 2371 |
|
2016
Q4 | $16K | Hold |
197
| – | – | ﹤0.01% | 2332 |
|
2016
Q3 | $22K | Buy |
197
+54
| +38% | +$6.03K | ﹤0.01% | 2202 |
|
2016
Q2 | $16K | Hold |
143
| – | – | ﹤0.01% | 2207 |
|
2016
Q1 | $15K | Hold |
143
| – | – | ﹤0.01% | 2212 |
|
2015
Q4 | $12K | Hold |
143
| – | – | ﹤0.01% | 2309 |
|
2015
Q3 | $10K | Buy |
+143
| New | +$10K | ﹤0.01% | 2002 |
|